CRF system and mood disorders

被引：28

作者：

Aubry, Jean-Michel ^{[1
]}

机构：

[1] Hop Univ Geneve, Dept Mental Hlth & Psychiat, Div Psychiat Specialties, Mood Disorder Program, CH-1201 Geneva, Switzerland

来源：

JOURNAL OF CHEMICAL NEUROANATOMY | 2013年 / 54卷

关键词：

Bipolar disorders; Depression; Stress reactivity; CRF antagonists; Antidepressant response; CORTICOTROPIN-RELEASING-FACTOR; MESSENGER-RNA EXPRESSION; FACTOR-LIKE IMMUNOREACTIVITY; IMPAIRED STRESS-RESPONSE; HORMONE-BINDING PROTEIN; RAT-BRAIN; MAJOR DEPRESSION; ANTIDEPRESSANT TREATMENT; ELEVATED CONCENTRATIONS; TYROSINE-HYDROXYLASE;

D O I：

10.1016/j.jchemneu.2013.09.003

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

070307 [化学生物学]; 071010 [生物化学与分子生物学];

摘要：

Since CRF discovery, there has been an impressive accumulation of data regarding the role of the CRF system in the regulation of the stress response. The link between stress and induction of a mood episode in the context of unipolar or bipolar disorder has been clearly demonstrated in several studies and is confirmed by clinical practice, particularly in bipolar disorder. Antidepressant-like effects of CRFR1 antagonists in different animal models of depression have generated a strong interest in the clinical development of CRFR1 antagonist for the treatment of major depressive disorder. These efforts have so far not been rewarded by clinical efficacy. However, this therapeutic approach is still being explored. Finally, the accumulated genetic findings, mostly those related to variants within CRFR1, point to a role of the CRF system in the pathophysiology of depression and anxiety. (C) 2013 Elsevier B.V. All rights reserved.

引用

页码：20 / 24

页数：5

共 83 条

[1]

Altman Susan, 2006, J Psychiatr Pract, V12, P269, DOI 10.1097/00131746-200609000-00002

[2]

HYPOTHALAMIC CONTROL OF ADRENOCORTICOTROPIN SECRETION - ADVANCES SINCE THE DISCOVERY OF 41-RESIDUE CORTICOTROPIN-RELEASING FACTOR [J].